Altimmune Inc (ALT) is lower by 5.42% Tuesday In Premarket Trading

Altimmune Inc (ALT) has fallen Tuesday morning, with the stock decreasing -5.42% in pre-market trading to 10.65. ALT's short-term technical score of 85 indicates that the stock has traded more bullishly over the last month than 85% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, ALT ranks higher than 92% of stocks. Altimmune Inc has risen 106.99% over the past month, closing at $5.84 on June 7. During this period of time, the stock fell as low as $5.84 and as high as $12.03. ALT has an average analyst recommendation of Strong Buy. The company has an average price target of $26.40.

ALT has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on ALT!

See Full ALT Report

Altimmune Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 88 by this metric, ALT ranks better than 88% of stocks.

Important Dates for Investors in ALT:

-Altimmune Inc is set to release earnings on 8/9/2022. Over the last 12 months, the company has reported EPS of $-2.41. -We do not have a set dividend date for Altimmune Inc at this time. Click Here To Get The Full Report on Altimmune Inc (ALT)